Literature DB >> 26265586

The estrogenic retina: The potential contribution to healthy aging and age-related neurodegenerative diseases of the retina.

Caterina Cascio1, Irene Deidda1, Domenica Russo1, Patrizia Guarneri2.   

Abstract

These last two decades have seen an explosion of clinical and epidemiological research, and basic research devoted to envisage the influence of gender and hormonal fluctuations in the retina/ocular diseases. Particular attention has been paid to age-related disorders because of the overlap of endocrine and neuronal dysfunction with aging. Hormonal withdrawal has been considered among risk factors for diseases such as glaucoma, diabetic retinopathy and age-related macular disease (AMD), as well as, for Alzheimer's disease, Parkinson's disease, or other neurodegenerative disorders. Sex hormones and aging have been also suggested to drive the incidence of ocular surface diseases such as dry eye and cataract. Hormone therapy has been approached in several clinical trials. The discovery that the retina is another CNS tissue synthesizing neurosteroids, among which neuroactive steroids, has favored these studies. However, the puzzling data emerged from clinical, epidemiological and experimental studies have added several dimensions of complexity; the current landscape is inherently limited to the weak information on the influence and interdependence of endocrine, paracrine and autocrine regulation in the retina, but also in the brain. Focusing on the estrogenic retina, we here review our knowledge on local 17β-oestradiol (E2) synthesis from cholesterol-based neurosteroidogenic path and testosterone aromatization, and presence of estrogen receptors (ERα and ERβ). The first cholesterol-limiting step and the final aromatase-limiting step are discussed as possible check-points of retinal functional/dysfunctional E2. Possible E2 neuroprotection is commented as a group of experimental evidence on excitotoxic and oxidative retinal paradigms, and models of retinal neurodegenerative diseases, such as glaucoma, diabetic retinopathy and AMD. These findings may provide a framework to support clinical studies, although further basic research is needed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol-metabolizing P450s; Oestradiol synthesis and receptors; P450 aromatase; Retinal neurodegenerative diseases; Retinal neurosteroidogenesis

Mesh:

Substances:

Year:  2015        PMID: 26265586     DOI: 10.1016/j.steroids.2015.08.002

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  22 in total

1.  Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea.

Authors:  In Cheol Hwang; Jeong Hun Bae; Joon Mo Kim
Journal:  Eye (Lond)       Date:  2019-02-13       Impact factor: 3.775

2.  Tamoxifen Provides Structural and Functional Rescue in Murine Models of Photoreceptor Degeneration.

Authors:  Xu Wang; Lian Zhao; Yikui Zhang; Wenxin Ma; Shaimar R Gonzalez; Jianguo Fan; Friedrich Kretschmer; Tudor C Badea; Hao-Hua Qian; Wai T Wong
Journal:  J Neurosci       Date:  2017-02-24       Impact factor: 6.167

3.  Predicting sex from retinal fundus photographs using automated deep learning.

Authors:  Edward Korot; Nikolas Pontikos; Xiaoxuan Liu; Siegfried K Wagner; Livia Faes; Josef Huemer; Konstantinos Balaskas; Alastair K Denniston; Anthony Khawaja; Pearse A Keane
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

4.  Zebrafish Optomotor Response and Morphology Are Altered by Transient, Developmental Exposure to Bisphenol-A.

Authors:  Mikayla Crowley-Perry; Angelo J Barberio; Jude Zeino; Erica R Winston; Victoria P Connaughton
Journal:  J Dev Biol       Date:  2021-04-02

5.  Assessment of polygenic effects links primary open-angle glaucoma and age-related macular degeneration.

Authors:  Gabriel Cuellar-Partida; Jamie E Craig; Kathryn P Burdon; Jie Jin Wang; Brendan J Vote; Emmanuelle Souzeau; Ian L McAllister; Timothy Isaacs; Stewart Lake; David A Mackey; Ian J Constable; Paul Mitchell; Alex W Hewitt; Stuart MacGregor
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

6.  Impact of aromatase absence on murine intraocular pressure and retinal ganglion cells.

Authors:  Xiaomin Chen; Yang Liu; Yi Zhang; Wendy R Kam; Louis R Pasquale; David A Sullivan
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

Review 7.  Gonadal Hormones and Retinal Disorders: A Review.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco; Giancarlo Panzica
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-02       Impact factor: 5.555

Review 8.  Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause.

Authors:  Raquel Marin; Mario Diaz
Journal:  Front Neurosci       Date:  2018-03-06       Impact factor: 4.677

9.  Testosterone Pathway Genetic Polymorphisms in Relation to Primary Open-Angle Glaucoma: An Analysis in Two Large Datasets.

Authors:  Jessica N Cooke Bailey; Puya Gharahkhani; Jae H Kang; Mariusz Butkiewicz; David A Sullivan; Robert N Weinreb; Hugues Aschard; R Rand Allingham; Allison Ashley-Koch; Richard K Lee; Sayoko E Moroi; Murray H Brilliant; Gadi Wollstein; Joel S Schuman; John H Fingert; Donald L Budenz; Tony Realini; Terry Gaasterland; William K Scott; Kuldev Singh; Arthur J Sit; Robert P Igo; Yeunjoo E Song; Lisa Hark; Robert Ritch; Douglas J Rhee; Douglas Vollrath; Donald J Zack; Felipe Medeiros; Thasarat S Vajaranant; Daniel I Chasman; William G Christen; Margaret A Pericak-Vance; Yutao Liu; Peter Kraft; Julia E Richards; Bernard A Rosner; Michael A Hauser; Jamie E Craig; Kathryn P Burdon; Alex W Hewitt; David A Mackey; Jonathan L Haines; Stuart MacGregor; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

10.  Factors Affecting Photopic Negative Response Recorded with RETeval System: Study of Young Healthy Subjects.

Authors:  Kumiko Kato; Asako Sugawara; Ryunosuke Nagashima; Kengo Ikesugi; Masahiko Sugimoto; Mineo Kondo
Journal:  Transl Vis Sci Technol       Date:  2020-08-10       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.